Department of Neurosurgery and Pituitary Tumor Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou China.
Department of Neurosurgery/Neuro-oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou China.
J Clin Endocrinol Metab. 2019 Jun 1;104(6):2419-2434. doi: 10.1210/jc.2018-01851.
Nonfunctioning pituitary adenomas (NFPAs) are the major cause of hypopituitarism and infertility. However, the pathogenesis of NFPAs remains largely unknown. Previous studies have demonstrated the crucial role of miRNAs in the progression of pituitary adenomas. Increasing evidence has indicated that circular RNAs (circRNAs) might mediate miRNA transcriptional activity, providing new insights to study the pathogenesis of NFPAs.
To explore the regulation and activity of the circRNA-miRNA-mRNA axis in the tumorigenesis of NFPAs.
The function of miR-145-5p in NFPAs was investigated invitro and invivo. The mechanical details were explored and potential targets of miR-145-5p were identified. Finally, miR-145-5p-associated circRNAs were functionally recognized and confirmed.
miR-145-5p was markedly decreased in NFPA samples and correlated negatively with NFPA invasiveness. Overexpression of miR-145-5p suppressed NFPA cell proliferation and invasiveness and promoted apoptosis. Further results confirmed that translationally controlled tumor protein (TPT1) is a target of miR-145-5p and mediated the effect of miR-145-5p. TPT1 and its downstream factors Mcl-1 and Bcl-xL were downregulated, and Bax was upregulated by miR-145-5p. Moreover, circOMA1 (hsa_circRNA_0002316) was demonstrated to sponge miR-145-5p, whose suppression on NFPA cells was abrogated by circOMA1 overexpression. circOMA1 silencing exhibited a similar inhibitory effect with miR-145-5p overexpression by downregulating TPT1. We found that circOMA1 could further upregulate Mcl-1 and Bcl-xL and downregulate Bax.
circOMA1 promotes NFPA progression by acting as the sponge of tumor suppressor miR-145-5p to regulate the TPT1 signaling pathway, revealing a therapeutic target in preventing the tumorigenesis of NFPAs.
无功能垂体腺瘤(NFPAs)是导致垂体功能减退和不育的主要原因。然而,NFPAs 的发病机制在很大程度上仍不清楚。先前的研究表明 microRNA(miRNA)在垂体腺瘤的进展中起着关键作用。越来越多的证据表明,环状 RNA(circRNA)可能介导 miRNA 的转录活性,为研究 NFPAs 的发病机制提供了新的见解。
探讨 circRNA-miRNA-mRNA 轴在 NFPAs 发生中的调控和活性。
在体外和体内研究了 miR-145-5p 在 NFPAs 中的作用。探讨了其机械细节,并鉴定了 miR-145-5p 的潜在靶标。最后,对 miR-145-5p 相关的 circRNA 进行了功能识别和验证。
miR-145-5p 在 NFPA 样本中明显下调,与 NFPA 的侵袭性呈负相关。过表达 miR-145-5p 抑制 NFPA 细胞增殖和侵袭,促进细胞凋亡。进一步的结果证实,翻译控制肿瘤蛋白(TPT1)是 miR-145-5p 的靶标,并介导了 miR-145-5p 的作用。TPT1 及其下游因子 Mcl-1 和 Bcl-xL 下调,Bax 上调。此外,circOMA1(hsa_circRNA_0002316)被证明可以海绵吸附 miR-145-5p,而过表达 circOMA1 则可消除其对 NFPA 细胞的抑制作用。circOMA1 沉默通过下调 TPT1,与 miR-145-5p 过表达具有相似的抑制作用。我们发现,circOMA1 可以进一步上调 Mcl-1 和 Bcl-xL,下调 Bax。
circOMA1 通过作为肿瘤抑制 miR-145-5p 的海绵来调节 TPT1 信号通路,促进 NFPA 的进展,揭示了预防 NFPAs 发生的治疗靶点。